bioAffinity Technologies, Inc. (NASDAQ:BIAFW – Get Rating) shares fell 7.6% on Tuesday . The stock traded as low as $0.35 and last traded at $0.49. 9,877 shares changed hands during trading, a decline of 70% from the average session volume of 33,233 shares. The stock had previously closed at $0.53.
bioAffinity Technologies Trading Down 7.6 %
The firm has a 50-day simple moving average of $0.43.
Get bioAffinity Technologies alerts:Institutional Investors Weigh In On bioAffinity Technologies
An institutional investor recently bought a new position in bioAffinity Technologies stock. Armistice Capital LLC acquired a new stake in bioAffinity Technologies, Inc. (NASDAQ:BIAFW – Get Rating) during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm acquired 204,082 shares of the company's stock, valued at approximately $72,000.
About bioAffinity Technologies
(Get Rating)bioAffinity Technologies, Inc, a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat cancer at the cellular level.
See Also
- Get a free copy of the StockNews.com research report on bioAffinity Technologies (BIAFW)
- Will Nordstrom Stock be the Grinch This Year?
- Harpoon Therapeutics Remains Volatile After Promising News
- We Are the Champions: 3 Dividend Growers Wall Street Loves
- What is Market Structure in Trading?
- Institutional Selling Is No Headwind For Nike
Receive News & Ratings for bioAffinity Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for bioAffinity Technologies and related companies with MarketBeat.com's FREE daily email newsletter.